Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
AI Program Reveals Cellular Neighborhoods in Cancer Microenvironments

AI Program Reveals Cellular Neighborhoods in Cancer Microenvironments

Microbial Sensor Unlocks Path to Personalized Blood Stem Cell Therapy

Microbial Sensor Unlocks Path to Personalized Blood Stem Cell Therapy

Microbial Sensor Plays Key Role in Blood Stem Cell Development

Microbial Sensor Plays Key Role in Blood Stem Cell Development

Study Elucidates How Mutant NPM1 Protein Drives Leukemia by Activating Autophagy System

Study Elucidates How Mutant NPM1 Protein Drives Leukemia by Activating Autophagy System

New Irreversible Inhibitor Overcomes Drug Resistance in Cancer Cells

New Irreversible Inhibitor Overcomes Drug Resistance in Cancer Cells

Nutrient Derived From Meat and Dairy Enhances Cancer Killing Ability of Immune Cells

Nutrient Derived From Meat and Dairy Enhances Cancer Killing Ability of Immune Cells

Gene Splicing Affects CD20 Expression and Response to Cancer Immunotherapy

Gene Splicing Affects CD20 Expression and Response to Cancer Immunotherapy

Wilmot Researchers Uncover a "Genomic Tug of War" That Influences Decitabine's Effectiveness

Wilmot Researchers Uncover a "Genomic Tug of War" That Influences Decitabine's Effectiveness

New Insights Into Tumor-Immune Interactions Could Lead to More Effective Therapies for Multiple Myeloma

New Insights Into Tumor-Immune Interactions Could Lead to More Effective Therapies for Multiple Myeloma

Novel Activation Mechanism for First Identified Oncogene

Novel Activation Mechanism for First Identified Oncogene

Researchers Develop Bio-Inspired Drug to Boost Efficacy of Cancer Immunotherapy

Researchers Develop Bio-Inspired Drug to Boost Efficacy of Cancer Immunotherapy

Research Offers a Promising Avenue for Improving T-Cell-Based Cancer Therapies

Research Offers a Promising Avenue for Improving T-Cell-Based Cancer Therapies

How RNA Regulates Gene Silencing Could Pave Way for Novel Cancer Therapies

How RNA Regulates Gene Silencing Could Pave Way for Novel Cancer Therapies

The Mechanism of Immune Memory Development

The Mechanism of Immune Memory Development

Deep Learning Model Accurately Predicts RNA-Targeting CRISPR Activity

Deep Learning Model Accurately Predicts RNA-Targeting CRISPR Activity

Mechanisms of MCL-1 Inhibitor-Induced MCL-1 Protein Upregulation and Induction of Apoptosis

Mechanisms of MCL-1 Inhibitor-Induced MCL-1 Protein Upregulation and Induction of Apoptosis

Cell Fate Conversion Plays Crucial Role in Cancer Research

Cell Fate Conversion Plays Crucial Role in Cancer Research

Liver Cancers With Key Epigenetic Alteration Tend to Have a Poor Clinical Prognosis

Liver Cancers With Key Epigenetic Alteration Tend to Have a Poor Clinical Prognosis

Understanding the Motility of H. pylori Using 3D Model

Understanding the Motility of H. pylori Using 3D Model

Researchers Create a Computational Tool to Gain New Insights From Multi-Omics Data

Researchers Create a Computational Tool to Gain New Insights From Multi-Omics Data

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.